Oxysterols as markers of neurological disease - A review

Valerio Leoni

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Cholesterol plays a crucial structural role in the brain and local synthesis covers almost all the requirements of the brain. To maintain homeostasis, the excess of cholesterol is converted into the more hydrophilic oxysterol 24S-hydroxycholesterol by the neuron-specific enzyme CYP46A1. About 99 % of the total excretion of this oxysterol by the brain occurs across the blood-brain barrier directly into the bloodstream. Almost all the 24S-hydroxycholesterol present in human circulation has a cerebral origin and its concentrations depend on the number of metabolically active neurons located in the grey matter of the brain. Neurodegeneration, with loss of neurons, and the subsequent brain atrophy are associated with significantly reduced concentrations of oxysterols. 24S-Hydroxycholesterol can thus be used as a surrogate marker of brain atrophy in neurodegenerative diseases such as Alzheimer and multiple sclerosis. Less than 1 % of the total excretion of 24S-hydroxycholesterol is via the cerebrospinal fluid. This small fraction appears to reflect neuronal damage and rate of neuronal loss rather than the total number of metabolically active neuronal cells. Patients with neurodegenerative disorders have thus been found to have increased concentrations of 24S-hydroxycholesterol in cerebrospinal fluid, in parallel with decreased concentrations in the circulation. Compared with other available biomarkers in CSF, such as Total Tau, Phospo-Tau and β 42 amyloid, the 24S-hydroxycholesterol appears to be the most sensitive biomarker in the evaluation of patients with cognitive impairment disease.

Original languageEnglish
Pages (from-to)22-25
Number of pages4
JournalScandinavian Journal of Clinical and Laboratory Investigation
Volume69
Issue number1
DOIs
Publication statusPublished - Feb 2009

Fingerprint

Brain
Neurons
Cerebrospinal fluid
Biomarkers
Neurodegenerative Diseases
Atrophy
Cerebrospinal Fluid
Cholesterol
Neurodegenerative diseases
Blood-Brain Barrier
Amyloid
Multiple Sclerosis
Oxysterols
24-hydroxycholesterol
Alzheimer Disease
Homeostasis
Enzymes

Keywords

  • 24S-hydroxycholesterol
  • 27-hydroxycholesterol
  • Alzheimer disease
  • Cerebrospinal fluid
  • Cholesterol
  • Gas chromatography mass spectrometry
  • Multiple sclerosis
  • Neurodegeneration

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Oxysterols as markers of neurological disease - A review. / Leoni, Valerio.

In: Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 69, No. 1, 02.2009, p. 22-25.

Research output: Contribution to journalArticle

@article{235f3047fcb1453296d3ec74b19ce924,
title = "Oxysterols as markers of neurological disease - A review",
abstract = "Cholesterol plays a crucial structural role in the brain and local synthesis covers almost all the requirements of the brain. To maintain homeostasis, the excess of cholesterol is converted into the more hydrophilic oxysterol 24S-hydroxycholesterol by the neuron-specific enzyme CYP46A1. About 99 {\%} of the total excretion of this oxysterol by the brain occurs across the blood-brain barrier directly into the bloodstream. Almost all the 24S-hydroxycholesterol present in human circulation has a cerebral origin and its concentrations depend on the number of metabolically active neurons located in the grey matter of the brain. Neurodegeneration, with loss of neurons, and the subsequent brain atrophy are associated with significantly reduced concentrations of oxysterols. 24S-Hydroxycholesterol can thus be used as a surrogate marker of brain atrophy in neurodegenerative diseases such as Alzheimer and multiple sclerosis. Less than 1 {\%} of the total excretion of 24S-hydroxycholesterol is via the cerebrospinal fluid. This small fraction appears to reflect neuronal damage and rate of neuronal loss rather than the total number of metabolically active neuronal cells. Patients with neurodegenerative disorders have thus been found to have increased concentrations of 24S-hydroxycholesterol in cerebrospinal fluid, in parallel with decreased concentrations in the circulation. Compared with other available biomarkers in CSF, such as Total Tau, Phospo-Tau and β 42 amyloid, the 24S-hydroxycholesterol appears to be the most sensitive biomarker in the evaluation of patients with cognitive impairment disease.",
keywords = "24S-hydroxycholesterol, 27-hydroxycholesterol, Alzheimer disease, Cerebrospinal fluid, Cholesterol, Gas chromatography mass spectrometry, Multiple sclerosis, Neurodegeneration",
author = "Valerio Leoni",
year = "2009",
month = "2",
doi = "10.1080/00365510802651858",
language = "English",
volume = "69",
pages = "22--25",
journal = "Scandinavian Journal of Clinical and Laboratory Investigation",
issn = "0036-5513",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Oxysterols as markers of neurological disease - A review

AU - Leoni, Valerio

PY - 2009/2

Y1 - 2009/2

N2 - Cholesterol plays a crucial structural role in the brain and local synthesis covers almost all the requirements of the brain. To maintain homeostasis, the excess of cholesterol is converted into the more hydrophilic oxysterol 24S-hydroxycholesterol by the neuron-specific enzyme CYP46A1. About 99 % of the total excretion of this oxysterol by the brain occurs across the blood-brain barrier directly into the bloodstream. Almost all the 24S-hydroxycholesterol present in human circulation has a cerebral origin and its concentrations depend on the number of metabolically active neurons located in the grey matter of the brain. Neurodegeneration, with loss of neurons, and the subsequent brain atrophy are associated with significantly reduced concentrations of oxysterols. 24S-Hydroxycholesterol can thus be used as a surrogate marker of brain atrophy in neurodegenerative diseases such as Alzheimer and multiple sclerosis. Less than 1 % of the total excretion of 24S-hydroxycholesterol is via the cerebrospinal fluid. This small fraction appears to reflect neuronal damage and rate of neuronal loss rather than the total number of metabolically active neuronal cells. Patients with neurodegenerative disorders have thus been found to have increased concentrations of 24S-hydroxycholesterol in cerebrospinal fluid, in parallel with decreased concentrations in the circulation. Compared with other available biomarkers in CSF, such as Total Tau, Phospo-Tau and β 42 amyloid, the 24S-hydroxycholesterol appears to be the most sensitive biomarker in the evaluation of patients with cognitive impairment disease.

AB - Cholesterol plays a crucial structural role in the brain and local synthesis covers almost all the requirements of the brain. To maintain homeostasis, the excess of cholesterol is converted into the more hydrophilic oxysterol 24S-hydroxycholesterol by the neuron-specific enzyme CYP46A1. About 99 % of the total excretion of this oxysterol by the brain occurs across the blood-brain barrier directly into the bloodstream. Almost all the 24S-hydroxycholesterol present in human circulation has a cerebral origin and its concentrations depend on the number of metabolically active neurons located in the grey matter of the brain. Neurodegeneration, with loss of neurons, and the subsequent brain atrophy are associated with significantly reduced concentrations of oxysterols. 24S-Hydroxycholesterol can thus be used as a surrogate marker of brain atrophy in neurodegenerative diseases such as Alzheimer and multiple sclerosis. Less than 1 % of the total excretion of 24S-hydroxycholesterol is via the cerebrospinal fluid. This small fraction appears to reflect neuronal damage and rate of neuronal loss rather than the total number of metabolically active neuronal cells. Patients with neurodegenerative disorders have thus been found to have increased concentrations of 24S-hydroxycholesterol in cerebrospinal fluid, in parallel with decreased concentrations in the circulation. Compared with other available biomarkers in CSF, such as Total Tau, Phospo-Tau and β 42 amyloid, the 24S-hydroxycholesterol appears to be the most sensitive biomarker in the evaluation of patients with cognitive impairment disease.

KW - 24S-hydroxycholesterol

KW - 27-hydroxycholesterol

KW - Alzheimer disease

KW - Cerebrospinal fluid

KW - Cholesterol

KW - Gas chromatography mass spectrometry

KW - Multiple sclerosis

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=61649126681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61649126681&partnerID=8YFLogxK

U2 - 10.1080/00365510802651858

DO - 10.1080/00365510802651858

M3 - Article

C2 - 19199127

AN - SCOPUS:61649126681

VL - 69

SP - 22

EP - 25

JO - Scandinavian Journal of Clinical and Laboratory Investigation

JF - Scandinavian Journal of Clinical and Laboratory Investigation

SN - 0036-5513

IS - 1

ER -